Kathryn M Field, John Simes, Anna K Nowak, Lawrence Cher, Helen Wheeler, Elizabeth J Hovey, Christopher SB Brown, Elizabeth H Barnes, Kate Sawkins, Ann Livingstone, Ron Freilich, Pramit M Phal, Greg Fitt, CABARET/COGNO investigators, Mark A Rosenthal, CABARET/COGNO investigators, K Field, J Simes, E Hovey, A Nowak, L Cher, H Wheeler, C Brown, E Barnes, K Sawkins, A Livingstone, M Rosenthal, P Phal, G Fitt, C Goh, M Tattersall, P Kelly, A Hayden, K Sawkins, C Brown, L Barnes, A Livingstone, D Winter, B Tomes, R Pike, J Simes, R Freilich, I Arzhintar, K Field, M Rosenthal, L Garrett, J Simes, A Byrne, A Dowling, N Ranieri, R Jennens, F Osmond, WK Patterson, A Phay, F Abell, L Plowman, L Cher, J Flynn, E Hovey, H Kilsby, H Wheeler, S Kirby-Lewis, N Singhal, S Smith, M Whelan, P Inglis, A Ives, A Nowak, S Lobb, S Begbie, P Williams, Z Lwin, N Woodward, G Crosbie, R Harrup, L Pyszkowski, S Gauden, A Neville,
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma Neuro-oncology. ,vol. 17, pp. 1504- 1513 ,(2015) ,
10.1093/NEUONC/NOV104